| Rank | Ticker | Exchange | Price | Market Cap | 52W High | 52W Low | Analyst Rating |
|---|---|---|---|---|---|---|---|
#1 | COST | Nasdaq | $867.50 | $379.4B | $1,078.24 | $844.06 | Buy |
#2 | AMT | Nasdaq | $175.80 | $84.8B | $234.33 | $170.77 | Buy |
#3 | EOG | Nasdaq | $104.63 | $58.0B | $138.18 | $101.59 | Buy |
#4 | MSTR | Nasdaq | $155.98 | $57.4B | $457.22 | $154.12 | Strong Buy |
#5 | PSA | Nasdaq | $259.24 | $45.5B | $322.49 | $256.60 | Buy |
#6 | VICI | Nasdaq | $28.27 | $32.4B | $34.03 | $27.56 | Buy |
#7 | CDW | Nasdaq | $138.75 | $18.9B | $222.92 | $135.63 | Buy |
#8 | DOCS | Nasdaq | $44.09 | $12.3B | $85.21 | $43.25 | Buy |
The FinQuota filters have identified what they believe to be the "Blue Chip Stocks at 52 Week Lows (December 30, 2025) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.